Variable | Bivariate odds ratio (95% CI) | Multivariate odds ratio (95% CI) |
---|---|---|
Sex | ||
Female | 1.0 | 1.0 |
Male | 0.86 (0.77, 0.95) | 0.84 (0.72, 0.98) |
State | ||
Benue | 1.0 | 1.0 |
FCT | 0.70 (0.61, 0.80) | 0.40 (0.23, 0.69) |
Nasarawa | 0.68 (0.60, 0.76) | 0.40 (0.23, 0.69) |
Age at ART start†| ||
1st quartile | 1.0 | 1.0 |
2nd quartile | 0.93 (0.81, 1.07) | 0.81 (0.67, 1.00) |
3rd quartile | 0.93 (0.81, 1.07) | 0.79 (0.64, 0.98) |
4th quartile | 0.88 (0.76, 1.01) | 0.71 (0.57, 0.88) |
ART enrollment year | ||
2013 | 1.0 | 1.0 |
2014 | 1.06 (0.90, 1.26) | 1.14 (0.90, 1.44) |
2015 | 1.15 (0.98, 1.37) | 1.39 (1.06, 1.83) |
2016 | 1.24 (1.07, 1.45) | 1.64 (1.22, 2.22) |
2017 | 1.09 (0.92, 1.29) | 2.16 (1.51, 3.09) |
2018 | 1.13 (0.94, 1.40) | 2.15 (1.40, 3.32) |
2019 | 1.78 (1.16, 2.73) | * |
Duration on ART | ||
0–1 year | 1.0 | 1.0 |
1–2 years | 1.01 (0.88, 1.17) | 1.33 (1.02, 1.74) |
2–3 years | 0.99 (0.85, 1.14) | 1.68 (1.28, 2.19) |
3–4 years | 0.97 (0.82, 1.13) | 1.70 (1.27, 2.26) |
4 + years | 0.93 (0.81, 1.08) | 2.27 (1.62, 3.19) |
Facility support type | ||
Standard | 1.0 | 1.0 |
Model | 0.86 (0.78, 0.95) | 1.30 (1.13, 1.50) |
ARV refill duration | ||
1Â month | 1.0 | 1.0 |
2Â months | 1.59 (1.44, 1.76) | 1.18 (1.02, 1.36) |
3 + months | 2.14 (1.82, 2.52) | 1.94 (1.54, 2.43) |
Baseline CD4‡ | ||
1st quartile | 1.0 | 1.0 |
2nd quartile | 1.01 (0.86, 1.20) | 1.07 (0.87, 1.30) |
3rd quartile | 0.97 (0.82, 1.14) | 1.03 (0.85, 1.25) |
4th quartile | 0.63 (0.54, 0.74) | 0.69 (0.57, 0.83) |
ART regimen at start | ||
TDF based | 1.0 | 1.0 |
AZT based | 0.72 (0.64, 0.81) | 0.72 (0.61, 0.86) |
Other | * | 0.88 (0.31, 2.50) |
Contact tested | ||
No | 1.0 | 1.0 |
Yes | 1.16 (1.01, 1.33) | 1.19 (1.00, 1.41) |